摘要
非小细胞肺癌(NSCLC)术后辅助化疗出现于20世纪70年代,随着各种新药及新的联合化疗方案的出现,NSCLC的术后辅助化疗亦在不断地进展,越来越多的证据显示术后辅助化疗能提高NSCLC患者的生存期和生活质量,就NSCLC的术后辅助化疗现状进行了介绍并对其发展前景进行了展望。
The post-operative adjuvant chemotherapy （PAC） for non-small cell lung cancer （NSCLC） appeared on the 1970s of the 20th century. Along with the appearance of each kind of new drugs and new combined therapeutic regimen, PAC for NSCLC is also progressed gradually, and more and more evidence showed that PAC can improve the survival and quality of life of patients with NSCLC. The present situation of PAC for NSCLC and the prospects of its future development were introduced.
出处
《肿瘤研究与临床》
CAS
2006年第6期361-363,共3页
Cancer Research and Clinic
关键词
非小细胞肺癌
术后辅助化疗
Post-operative adjuvant chemotherapy
Non-small cell lung cancer
